Skip to main content

Featured

5 Things to Know Today (June 30): GDP Data, TSX Close, Ontario Insurance

  Tuesday, June 30, 2026 Fresh GDP numbers landed this morning, the TSX wrapped up Monday in the green, and Ontario drivers have a deadline starting tomorrow. Here's everything you need to know to start your Tuesday informed. 1 April GDP Data Is Out Statistics Canada released April GDP-by-industry numbers this morning, along with an early advance read on May. The release lands against a tricky backdrop: real GDP edged down slightly in both the fourth quarter of 2025 and the first quarter of 2026, putting Canada right at the edge of a technical recession. Most economists stop short of calling it one outright, pointing to one-off factors — a surge in gold imports chief among them — that distorted the headline number more than the underlying economy did. Forecasters had been pencilling in an April rebound of roughly 0.4%. We've got the full breakdown of today's release, and what it means for rate-cut odds, in a separate post on the site. 2 TSX Closes Higher, Markets Shut Wed...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment